Insider holders · CIK 0000908259
Oncotelic Therapeutics, Inc. · OTLC
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| Vuong TrieuCHAIRMAN AND CEO | 94,124,319 | 6,872,529 | 100,996,848 | Jul 14, 2026 · 4:00 pm EDT | Form 4 |
| William D SchwietermanPresident and CEO | 625,747 | — | 625,747 | Apr 16, 2018 · 4:23 pm EDT | Form 4 |
| Amit B. ShahCFO | 378,837 | — | 378,837 | Jun 22, 2026 · 4:30 pm EDT | Form 4 |
| Matthew M LoarChief Financial Officer | 300,000 | — | 300,000 | Apr 16, 2018 · 4:22 pm EDT | Form 4 |
| Donald Rogers ReynoldsDirector | 280,000 | — | 280,000 | Apr 16, 2018 · 4:24 pm EDT | Form 4 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.